239,95 €
239,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
120 °P sammeln
239,95 €
239,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
120 °P sammeln
Als Download kaufen
239,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
120 °P sammeln
Jetzt verschenken
239,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
120 °P sammeln
  • Format: PDF

The Classic Text-Expanded, Updated...More Authoritative than Ever!Cutaneous Melanoma is the definitive and most authoritative textbook on melanoma used worldwide. This 5th edition provides the most up-to-date and comprehensive information needed for the clinical management and scientific study of melanoma. Written by the leading melanoma experts from the United States, Australia, and Europe, this new edition collectively incorporates the clinical outcomes of more than 60,000 patients treated at major melanoma centers throughout the world.Comprehensive Coverage-from Prevention to Advanced…mehr

Produktbeschreibung
The Classic Text-Expanded, Updated...More Authoritative than Ever!Cutaneous Melanoma is the definitive and most authoritative textbook on melanoma used worldwide. This 5th edition provides the most up-to-date and comprehensive information needed for the clinical management and scientific study of melanoma. Written by the leading melanoma experts from the United States, Australia, and Europe, this new edition collectively incorporates the clinical outcomes of more than 60,000 patients treated at major melanoma centers throughout the world.Comprehensive Coverage-from Prevention to Advanced TreatmentThis new edition provides in-depth coverage, ranging from precursors of melanoma to advanced stages of metastatic disease; from melanoma genes to population-based epidemiology; and from prevention of melanoma to all forms of multidisciplinary treatments. Basic principles of diagnosis and pathologic examination are combined with treatment approaches for the many clinical presentations. Clinical management is supported by statistical data about natural history, prognosis, and treatment results. The latest information on staging and prognosis, as well as randomized prospective clinical trials involving surgical treatment and systemic treatments, is included. This volume presents a balanced perspective of the risks and benefits involved in each treatment modality. The book also contains: 1) a comprehensive color atlas of melanoma and its precursors, 2) illustrated surgical and perfusion techniques for every stage and anatomic location of melanoma, and 3) complex genetic and molecular pathways involving melanoma biology. Every drug and biologic agent in use today is described with indications and efficacy.Entirely Revised and UpdatedSeven new chapters discuss the emerging clinical data on the use of biomarkers, adjuvant therapies, targeted therapies, and immune modulation as well as significant clinical research a

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Charles Balch Professor of Surgery, Oncology, and Dermatology, Johns Hopkins School of Medicine; Deputy Director for Clinical Trials and Outcomes Research, Institute for Clinical and Translational Research, Johns Hopkins Medical Institutions, Baltimore, Maryland. Alan Houghton, Vice Chairman, Member, Department of Medicine and Immunology; Professor of Immunology, Gerstner Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York. Arthur Sober, Professor, Department of Dermatology, Harvard Medical School; Director, Medical Dermatology, Massachusetts General Hospital, Boston, Massachusetts. Seng-jaw Soong, Professor Emeritus of Medicine, Department of Medicine; Director Emeritus, Biostatistics and Bioinformatics Unit; Associate Director Emeritus of the Comprehensive Cancer Center, University of Alabama at Birmingham. Michael Atkins, Professor of Medicine, Harvard Medical School; Deputy Chief, Division of Hematology/Oncology; Director, Cancer Clinical Trials Office and Cutaneous Oncology Program, Beth Israel Deaconess Medical Center, Boston. John Thompson, Professor of Melanoma and Surgical Oncology, Discipline of Surgery, Faculty of Medicine, the University of Sydney; Director, Sydney Melanoma Unit and Melanoma Institute Australia, Royal Prince Alfred and Mater Hospitals, Sydney, Australia.